Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Current Leases for 7 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • For Q4 2025, Current Leases rose 1357.71% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 1357.71%, while the annual FY2025 figure was $2.6 million, 1357.71% up from the prior year.
  • Current Leases hit $2.6 million in Q4 2025 for Bicycle Therapeutics, up from $199000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $5.4 million in Q3 2024 and bottomed at $175000.0 in Q4 2024.
  • Average Current Leases over 5 years is $2.8 million, with a median of $2.9 million recorded in 2022.
  • Year-over-year, Current Leases plummeted 96.41% in 2024 and then skyrocketed 1357.71% in 2025.
  • Bicycle Therapeutics' Current Leases stood at $2.4 million in 2021, then surged by 31.14% to $3.1 million in 2022, then soared by 56.03% to $4.9 million in 2023, then tumbled by 96.41% to $175000.0 in 2024, then surged by 1357.71% to $2.6 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $2.6 million, $199000.0, and $184000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.